SynthesisIranian journal of medical sciences2026
Indirect Costs of Non-Communicable Diseases within the Top Ten Causes of Mortality Worldwide: A Systematic Literature Review.
Synthesis in Iranian journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic non-communicable diseases (NCDs) are a major public health challenge, representing the leading cause of disability and premature mortality worldwide. Beyond direct medical expenses, NCDs generate substantial indirect costs through productivity losses and reduced workforce participation. This study aims to identify the indirect costs reported in scientific literature on NCDs in the economically active population between 2012 and 2022. Methods: A systematic literature review covering 2012 to 2025 was conducted in PubMed/MEDLINE, PubMed Central (PMC), Embase, Web of Science, and Scopus. Only primary studies in English or Spanish were included, and independent reviews were conducted by two authors. Results: Of 1980 identified articles, 42 met the inclusion criteria. Indirect costs were mainly represented by productivity losses (absenteeism and presenteeism) and disease burden measured with Disability-Adjusted Life Years (DALYs). The highest volume of research focused on ischemic heart disease, stroke, and chronic obstructive pulmonary disease. Conclusion: Evidence on indirect costs of NCDs remains limited despite their significant economic and social impact. These conditions reduce both the quality and availability of the workforce and generate high indirect costs. Addressing these challenges requires strategies across all levels of prevention, not only within healthcare systems but also in workplaces, to mitigate the economic burden of NCDs on the economically active population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.